🔴 Axsome Therapeutics Inc is trading 4.2% down today in a likely profit-taking move

Axsome Therapeutics Inc is trading 4.2% down at $220.64 as the stock gives back a portion of its recent gains following a period of positive regulatory and pipeline news.

• No fresh company-specific headlines, FDA updates, or analyst rating changes have been reported so far today.
• The downward move appears to be driven by profit-taking or normal market volatility rather than a reaction to new fundamental developments.
• The stock's decline comes despite a modestly positive session for the broader U.S. equity markets.